Abiopharma

🔍 Kim Peter Sung-Jip (Executive)

Company: LITTELFUSE INC /DE (LFUS)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Sold 4 shares of Common Stock at $407.14 per share (Direct)
  Date: 2026-04-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 11,223.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 319 shares of Common Stock at $407.14 per share (Direct)
  Date: 2026-04-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,904.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 229 shares of Common Stock at $407.14 per share (Direct)
  Date: 2026-04-25 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,675.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 158 shares of Common Stock at $403.02 per share (Direct)
  Date: 2026-04-27 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,517.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Closing price per share on the trading date of the vesting of dividend equivalent units or on the next preceding trading date if the vesting occurs on a non-trading date.
• F2: Closing price per share on the trading date of the vesting of restricted stock units or on the next preceding trading date if the vesting occurs on a non-trading date.